Securities and Exchange Board of India
SEBI : This article explains how Electronic Gold Receipts (EGRs) create a regulated, exchange-traded market backed by physical gold. It h...
CA, CS, CMA : This weekly roundup covers key notifications, circulars, and judicial rulings issued by GST, Customs, RBI, SEBI, MCA, IBBI, and ot...
SEBI : The SAT's ruling in Alpesh Vasanji Furiya v. SEBI is a significant clarification of the relationship between securities enforcem...
SEBI : SEBI flagged alleged revenue misrepresentation, undisclosed fund transfers, and accounting irregularities, raising concerns over d...
CA, CS, CMA : A comprehensive review of significant developments across Income Tax, GST, Customs, DGFT, SEBI, MCA, IBBI, and RBI. The update hig...
SEBI : SEBI has proposed significant changes to trading software and IT regulations by merging overlapping provisions and removing obsole...
SEBI : SEBI has proposed wide-ranging changes to the MTF framework to improve risk management and operational efficiency. The consultatio...
SEBI : SEBI has proposed a uniform framework for fixing price bands and pre-open base prices for scrips listed on multiple exchanges. The...
SEBI : SEBI has proposed replacing name-wise executive remuneration disclosures with consolidated disclosures for AMCs. The move seeks to...
SEBI : Following representations from the Bharat InvITs Association, SEBI has proposed amendments to NDCF computation rules. The draft in...
SEBI : The Supreme Court held that SEBI failed to establish fraud and market manipulation in RPL futures transactions. While disgorgement...
SEBI : SEBI overturned an earlier order that had exonerated the company, holding that key transactions allegedly created a misleading pic...
SEBI : The issue was whether failure to refund investor funds is time-barred. The Court held it is a continuing offence, rejecting the li...
Company Law : Supreme Court held that diversion of funds raised through preferential allotment for purposes other than those stated in offer doc...
SEBI : Calcutta High Court directs SEBI to accept Priya Ranjan Sah's payment, citing a one-day delay as not warranting prolonged litigati...
SEBI : SEBI has proposed a comprehensive overhaul of its Master Circulars to reduce compliance costs and simplify regulatory requirements...
SEBI : SEBI approved wide-ranging reforms covering transmission of securities, buy-backs, mutual funds, AIFs, municipal bonds, and securi...
SEBI : SEBI has clarified the applicability of the early pay-in facility in the commodity derivatives segment by revising its Master Circ...
SEBI : SEBI cautioned investors against trading unlisted public company securities on electronic platforms that are not recognized by the...
SEBI : SEBI has allowed AIFs to retain liquidation proceeds beyond the permissible fund life under specified conditions while introducing...
SEBI invites public comments on the procedure for seeking a waiver or reduction of interest on penalty recovery proceedings by Dec 2, 2024.
SEBI issues updated Master Circular for ICDR Regulations, consolidating directions till September 30, 2024, with a chapter-wise compliance framework.
SEBI issues updated Master Circular for LODR Regulations, consolidating compliance provisions for listed entities, stock exchanges, and other stakeholders.
Review of recent notifications and circulars for Income Tax, GST, SEBI, and IBBI from November 4-10, 2024, covering updated policies, SC rulings, and advisories.
SEBI outlines the procedure for reclassifying FPI investments to FDI for holdings exceeding 10% in Indian companies, effective immediately.
SEBI mandates brokers offer trading supported by blocked funds, including UPI block or 3-in-1 trading accounts, starting February 2025.
SEBI seeks public comments on revising the UPSI definition under Insider Trading Regulations for better clarity and compliance. Deadline: November 30, 2024.
SEBI denies Glenmark Life Sciences’ request for no-action relief, stating contra trade restrictions apply to its proposed share sale for minimum public shareholding compliance.
SEBI states sale to meet public shareholding norms isn’t exempt from insider trading rules, impacting Nirma’s share sale in Glenmark Life Sciences.
SEBI provides informal guidance to CMS Info Systems on promoter disclosures and nominee shareholder roles under LODR and ICDR regulations.
